Literature DB >> 31393191

Anxiety, depression and sleep disorders in patients with diabetic neuropathic pain: a systematic review.

Cristina Naranjo1,2, Leticia Del Reguero3, Guillermo Moratalla4, Miguel Hercberg4, Marta Valenzuela4, Inmaculada Failde2,3,5.   

Abstract

Introduction: Diabetic neuropathic pain (DNP) is a disabling complication suffered by patients with diabetic neuropathy. DNP coexists with different conditions, especially mental and sleep disorders, which seem to impair the management and course of the disease. However, there is a lack of accurate results about their prevalence. Consequently, the authors analyze the prevalence of anxiety, depression and/or sleep disorders in DND patients.Areas covered: Among the 206 articles found in the search, 8 studies with data from 5 different countries fulfilled the inclusion criteria. The prevalence of anxiety reported ranged between 7.8%-60.4% and that of depression between 13.6%- 50.6%. The two conditions coexist in 26.4%-30.6% in DND patients. A higher prevalence was found when the information was obtained using scales than when it came from medical records. The prevalence of sleep disorders found ranged from 41.6%-43.8%. However, there is lack of information about and the results are often expressed using the mean scores of the scales.Expert opinion: Although the data in the literature vary, a high prevalence of anxiety, depression and sleep comorbidities exists among patients with DNP. These results reaffirm the need to perform systematic evaluations and to identity their presence using validated instruments to obtain more reliable results.

Entities:  

Keywords:  Diabetic neuropathies; anxiety; comorbidity; depression; pain; sleep disorders

Mesh:

Year:  2019        PMID: 31393191     DOI: 10.1080/14737175.2019.1653760

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  16 in total

1.  Sleep Disturbance Alters Cocaine-Induced Locomotor Activity: Involvement of Striatal Neuroimmune and Dopamine Signaling.

Authors:  Soheil Kazemi Roodsari; Yan Cheng; Kirstin M Reed; Laurie L Wellman; Larry D Sanford; Woong-Ki Kim; Ming-Lei Guo
Journal:  Biomedicines       Date:  2022-05-18

2.  The early influence of COVID-19 pandemic-associated restrictions on pain, mood, and everyday life of patients with painful polyneuropathy.

Authors:  Dilara Kersebaum; Sophie-Charlotte Fabig; Manon Sendel; Juliane Sachau; Josephine Lassen; Stefanie Rehm; Philipp Hüllemann; Ralf Baron; Janne Gierthmühlen
Journal:  Pain Rep       Date:  2020-10-14

3.  Protective effects of dihydromyricetin on primary hippocampal astrocytes from cytotoxicity induced by comorbid diabetic neuropathic pain and depression.

Authors:  Huixiang Ge; Mengyun Sun; Xingyu Wei; Mingming Zhang; Hongcheng Tu; Yuanzhen Hao; Ruxin Chen; Miao Ye; Yun Gao
Journal:  Purinergic Signal       Date:  2020-11-06       Impact factor: 3.765

Review 4.  Metformin: A Prospective Alternative for the Treatment of Chronic Pain.

Authors:  Guadalupe Del Carmen Baeza-Flores; Crystell Guadalupe Guzmán-Priego; Leonor Ivonne Parra-Flores; Janet Murbartián; Jorge Elías Torres-López; Vinicio Granados-Soto
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

5.  Assessment of Pain and Associated Comorbidities: A Survey of Real Life Experiences Among Nurses in Italy.

Authors:  Chiara Angeletti; Paolo Matteo Angeletti; Martina Paesani; Cristiana Guetti; Aglaia Gyra; Gianluca Perseo; Alessandra Ciccozzi; Franco Marinangeli; Emma Altobelli
Journal:  J Pain Res       Date:  2021-01-25       Impact factor: 3.133

6.  Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes.

Authors:  Nathaniel M Putnam; Evan L Reynolds; Mousumi Banerjee; Kara Mizokami-Stout; Dana Albright; Joyce Lee; Rodica Pop-Busui; Eva L Feldman; Brian C Callaghan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-04       Impact factor: 5.555

7.  Meta-analysis of studies on depression prevalence among diabetes mellitus patients in Africa.

Authors:  Ropo Ebenezer Ogunsakin; Oludayo O Olugbara; Sibusiso Moyo; Connie Israel
Journal:  Heliyon       Date:  2021-05-21

8.  Sleep Characteristics in Diabetic Patients Depending on the Occurrence of Neuropathic Pain and Related Factors.

Authors:  Cristina Naranjo; María Dueñas; Carlos Barrera; Guillermo Moratalla; Inmaculada Failde
Journal:  Int J Environ Res Public Health       Date:  2020-11-03       Impact factor: 3.390

9.  Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients.

Authors:  Mohammadreza Davoudi; Parnian Rezaei; Fereshteh Rajaeiramsheh; Seyed Majid Ahmadi; Amir Abbas Taheri
Journal:  Health Qual Life Outcomes       Date:  2021-02-09       Impact factor: 3.186

10.  A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine.

Authors:  Daniela Rodrigues-Amorim; José Manuel Olivares; Carlos Spuch; Tania Rivera-Baltanás
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.